8-K/A
Current Report
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001078782-17-000908
Material agreement · New debt or obligation · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading f8ka062217_8kz.htm…